Trials / Unknown
UnknownNCT01131533
Intraocular Pharmacokinetics of Erythropoietin After Single Intravitreal Injection in Human
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (estimated)
- Sponsor
- Hallym University Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The investigators investigate intraocular concentrations and pharmacokinetics of erythropoietin after a single intravitreal injection in humans.
Detailed description
Intravitreal injections of erythropoietin for off-label use have been shown to be beneficial in eyes with diabetic macular edema.However, the pharmacokinetic profile of erythropoietin after intravitreal injection in humans has not yet been determined clearly. The purpose of this study was to determine the intraocular pharmacokinetics of erythropoietin after a single intravitreal injection in a prospective investigation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Vitrectomy | vitrectomy following intravitreal erythropoietin |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2010-07-01
- Completion
- 2011-12-01
- First posted
- 2010-05-27
- Last updated
- 2010-09-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01131533. Inclusion in this directory is not an endorsement.